Related references
Note: Only part of the references are listed.Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes
James F. Markmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus
Janet B. McGill et al.
JOURNAL OF DIABETES (2021)
Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial
Helga Blauw et al.
DIABETES CARE (2021)
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes
Grit Andersen et al.
DIABETES OBESITY & METABOLISM (2021)
The promise of stem cell-derived islet replacement therapy
Douglas Melton
DIABETOLOGIA (2021)
Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes
Fulya Erendor et al.
MOLECULAR THERAPY (2021)
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Robert Wagner et al.
NATURE MEDICINE (2021)
Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles
Abdul Ahad et al.
PHARMACEUTICS (2021)
Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes
Taylor M. Triolo et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Insulin and insulin analogs as antidiabetic therapy: A perspective from clinical trials
Caroline K. Kramer et al.
CELL METABOLISM (2021)
Human pluripotent stem cell-derived insulin-producing cells: A regenerative medicine perspective
Adriana Migliorini et al.
CELL METABOLISM (2021)
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
Harpreet S. Bajaj et al.
DIABETES CARE (2021)
A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
Ildiko Lingvay et al.
DIABETES CARE (2021)
Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide in Patients with Type 1 Diabetes (T1D) and Hypoglycemia Unawareness
Bart Keymeulen et al.
DIABETES (2021)
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
George Grunberger et al.
ENDOCRINE PRACTICE (2021)
Smartphone-Flashlight-Mediated Remote Control of Rapid Insulin Secretion Restores Glucose Homeostasis in Experimental Type-1 Diabetes
Maysam Mansouri et al.
SMALL (2021)
Tissue engineering and 3D printing of bioartificial pancreas for regenerative medicine in diabetes
Andreas Alvin Purnomo Soetedjo et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
A Model-Informed Drug Discovery and Development Strategy for the Novel Glucose-Responsive Insulin MK-2640 Enabled Rapid Decision Making
Sandra A. G. Visser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen
Peter Adolfsson et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Hypoglycaemia is reduced with use of inhaled Technosphere® Insulin relative to insulin aspart in type 1 diabetes mellitus
E. R. Seaquist et al.
DIABETIC MEDICINE (2020)
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(R)(Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study
Jennifer Leohr et al.
CLINICAL PHARMACOKINETICS (2020)
Fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge
Hideaki Kaneto et al.
DIABETES OBESITY & METABOLISM (2020)
The Evolution of Insulin and How it Informs Therapy and Treatment Choices
Irl B. Hirsch et al.
ENDOCRINE REVIEWS (2020)
Conformal Coating of Stem Cell-Derived Islets for β Cell Replacement in Type 1 Diabetes
Aaron A. Stock et al.
STEM CELL REPORTS (2020)
Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice
Krzysztof Krawczyk et al.
SCIENCE (2020)
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies
Christian Leborgne et al.
NATURE MEDICINE (2020)
A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells
Suman Bose et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Smarter Modeling to Enable a Smarter Insulin
Simeon I. Taylor et al.
DIABETES (2020)
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes A Randomized Clinical Trial
Richard E. Pratley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice
Que T. La et al.
CELLS (2020)
Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic Mice
Kian Chuan Sia et al.
CELLS (2020)
Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
Jonas Kildegaard et al.
PHARMACEUTICAL RESEARCH (2019)
Generation of hypoimmunogenic human pluripotent stem cells
Xiao Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A fully human transgene switch to regulate therapeutic protein production by cooling sensation
Peng Bai et al.
NATURE MEDICINE (2019)
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
Emanuele Bosi et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes
David Klonaff et al.
DIABETES CARE (2019)
Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
Yehuda Handelsman et al.
ADVANCES IN THERAPY (2019)
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
S. A. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Advances in transdermal insulin delivery
Yuqi Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetes
Shu Uin Gan et al.
JOURNAL OF GENE MEDICINE (2019)
Overview: an iPS cell stock at CiRA
Masafumi Umekage et al.
INFLAMMATION AND REGENERATION (2019)
Human iPSC banking: barriers and opportunities
Ching-Ying Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Transplantation of macroencapsulated human islets within the bioartificial pancreas Air to patients with type 1 diabetes mellitus
Per-Ola Carlsson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2018)
Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes
Xiangwei Xiao et al.
CELL STEM CELL (2018)
Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
Lutz Heinemann et al.
LANCET (2018)
Technology in the management of type 1 diabetes mellitus - current status and future prospects
Martin Tauschmann et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
Rodrigo Oliveira Moreira et al.
DIABETOLOGY & METABOLIC SYNDROME (2018)
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
Emma Ahlqvist et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial
John B. Buse et al.
DIABETES OBESITY & METABOLISM (2018)
Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques
Matthew A. Bochenek et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
Amine Meliani et al.
NATURE COMMUNICATIONS (2018)
Engineering Glucose Responsiveness Into Insulin
Niels C. Kaarsholm et al.
DIABETES (2018)
A glucose-responsive insulin therapy protects animals against hypoglycemia
Ruojing Yang et al.
JCI INSIGHT (2018)
An arduous journey from human pluripotent stem cells to functional pancreatic beta cells
Larry Sai Weng Loo et al.
DIABETES OBESITY & METABOLISM (2018)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial
Roy W. Beck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Generation of glucose-sensitive insulin-secreting beta-like cells from human embryonic stem cells by incorporating a synthetic lineage-control network
Pratik Saxena et al.
JOURNAL OF BIOTECHNOLOGY (2017)
Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
Lixin Guo et al.
MEDICINE (2017)
Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9
Dong Niu et al.
SCIENCE (2017)
Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs
Maria Luisa Jaon et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis
Jose A. G. Pertusa et al.
PLOS ONE (2017)
Current issues in allogeneic islet transplantation
Charles A. Chang et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2017)
Precision diabetes: learning from monogenic diabetes
Andrew T. Hattersley et al.
DIABETOLOGIA (2017)
Correction of Murine Diabetic Hyperglycaemia With A Single Systemic Administration of An AAV2/8 Vector Containing A Novel Codon Optimized Human Insulin Gene
Gan Shu Uin et al.
CURRENT GENE THERAPY (2016)
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia
Bernhard J. Hering et al.
DIABETES CARE (2016)
Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home
H. Blauw et al.
DIABETES OBESITY & METABOLISM (2016)
A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells
Pratik Saxena et al.
NATURE COMMUNICATIONS (2016)
Recent Progress in Xenotransplantation, with Emphasis on Virological Safety
Joachim Denner
ANNALS OF TRANSPLANTATION (2016)
Reprogramming of liver cells into insulin-producing cells
Irit Meivar-Levy et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Long-term glycemic control with hepatic insulin gene therapy in streptozotocin-diabetic mice
Peter M. Thule et al.
JOURNAL OF GENE MEDICINE (2015)
Treatment of diabetes with encapsulated pig islets: an update on current developments
Hai-tao Zhu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Genome-wide inactivation of porcine endogenous retroviruses (PERVs)
Luhan Yang et al.
SCIENCE (2015)
Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device
Andrew R. Pepper et al.
TRANSPLANTATION (2015)
Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
Dachun Wang et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
New forms of insulin and insulin therapies for the treatment of type 2 diabetes
Avivit Cahn et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Insulin-Producing Intestinal K Cells Protect Nonobese Diabetic Mice From Autoimmune Diabetes
Majid Mojibian et al.
GASTROENTEROLOGY (2014)
Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
Foad Rouhani et al.
PLOS GENETICS (2014)
Pig-Islet Xenotransplantation: Recent Progress and Current Perspectives
Hai-Tao Zhu et al.
FRONTIERS IN SURGERY (2014)
The TheraCyte (TM) Device Protects Against Islet Allograft Rejection in Immunized Hosts
Makiko Kumagai-Braesch et al.
CELL TRANSPLANTATION (2013)
Treatment of Diabetes and Long-Term Survival After Insulin and Glucokinase Gene Therapy
David Callejas et al.
DIABETES (2013)
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions
David M. Nathan et al.
DIABETES (2013)
Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy
Binhai Ren et al.
JOURNAL OF GENE MEDICINE (2013)
Correction of Diabetic Hyperglycemia and Amelioration of Metabolic Anomalies by Minicircle DNA Mediated Glucose-Dependent Hepatic Insulin Production
Tausif Alam et al.
PLOS ONE (2013)
Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010
Franca B. Barton et al.
DIABETES CARE (2012)
Reversal of Diabetes Through Gene Therapy of Diabetic Rats by Hepatic Insulin Expression via Lentiviral Transduction
Matthias Elsner et al.
MOLECULAR THERAPY (2012)
Long-acting basal insulin analogs: latest developments and clinical usefulness
Anastasia N. Mavrogiannaki et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2012)
History of insulin
Celeste C. Quianzon et al.
JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES (2012)
Characterization of Human Umbilical Cord Lining-Derived Epithelial Cells and Transplantation Potential
Yue Zhou et al.
CELL TRANSPLANTATION (2011)
Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology
Elsemiek E. C. Engwerda et al.
DIABETES CARE (2011)
Remission of Diabetes by Insulin Gene Therapy Using a Hepatocyte-specific and Glucose-responsive Synthetic Promoter
Jaeseok Han et al.
MOLECULAR THERAPY (2011)
Long-Term Insulin-Independence After Allogeneic Islet Transplantation for Type 1 Diabetes: Over the 10-Year Mark
T. Berney et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Treatment of diabetes by transplantation of drug-inducible insulin-producing gut cells
Suraj Unniappan et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Beyond the era of NPH insulin - Long-acting insulin analogs: Chemistry, comparative pharmacology, and clinical application
D. R. Owens et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2008)
Nonvirally Modified Autologous Primary Hepatocytes Correct Diabetes and Prevent Target Organ Injury in a Large Preclinical Model
Nelson K. F. Chen et al.
PLOS ONE (2008)
Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy
B. Ren et al.
DIABETOLOGIA (2007)
Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes
Jay S. Skyler et al.
DIABETES CARE (2007)
Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation
Robert B. Elliott et al.
XENOTRANSPLANTATION (2007)
Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
Amit C. Nathwani et al.
BLOOD (2007)
Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene
Jian Xu et al.
WORLD JOURNAL OF SURGERY (2007)
Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies
T. Heise et al.
DIABETES OBESITY & METABOLISM (2007)
International trial of the edmonton protocol for islet transplantation
A. M. James Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pramlintide in the treatment of type 1 and type 2 diabetes mellitus
GJ Ryan et al.
CLINICAL THERAPEUTICS (2005)
Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
J Rosenstock et al.
DIABETES CARE (2005)
Effective islet isolation method with extremely high islet yields from adult pigs
Y Yonekawa et al.
CELL TRANSPLANTATION (2005)
In vivo gene transfer to pancreatic beta cells by systemic delivery of adenoviral vectors
E Ayuso et al.
HUMAN GENE THERAPY (2004)
Hepatic insulin gene therapy in insulin-dependent diabetes mellitus
PC Nett et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Intensive replacement of basal insulin on patients with type 1 diabetes given rapid-acting insulin analog at mealtime - A 3-month comparsion between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime
P Rossetti et al.
DIABETES CARE (2003)
Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer
A Auricchio et al.
GENE THERAPY (2002)
Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats
HJ Dong et al.
DIABETES (2002)
Adenovirus-mediated preproinsulin gene transfer into adipose tissues ameliorated hyperglycemia in obese diabetic KKAy mice
S Nagamatsu et al.
FEBS LETTERS (2001)
Gene and cell-replacement therapy in the treatment of type 1 diabetes -: How high must the standards be set?
PA Halban et al.
DIABETES (2001)
Hepatic insulin expression improves glycemic control in type 1 diabetes rats
HJ Dong et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2001)
Regulated hepatic insulin gene therapy of STZ-diabetic rats
PM Thulé et al.
GENE THERAPY (2000)
The use of human ultralente is limited by great intraindividual variability in overnight plasma insulin profiles
T Lindström et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2000)
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
AMJ Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Adenovirus-mediated insulin gene transfer improves nutritional and post-hepatectomized conditions in diabetic rats
M Yamaguchi et al.
SURGERY (2000)
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo
L Heinemann et al.
DIABETES CARE (2000)
Share Paper
